Anzeige
Mehr »
Login
Donnerstag, 28.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Spezial am Donnerstag: Rallye II. - Neuer Anstoß, News und was die Börsencommunity jetzt nicht verpassen will…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
39 Leser
Artikel bewerten:
(0)

Asia Pacific Cardiac Pacemaker Market Outlook to 2019 - Medtronic, Biotronik, Boston Scientific Dominates the Market


DUBLIN, Nov. 26, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/lttqph/asia_pacific) has announced the addition of the "Asia Pacific Cardiac Pacemaker Market Outlook to 2019 - Rise in Cardiac Disorders and Growing Awareness among People to Drive the Demand " report to their offering.

The market is dominated by few global players including Medtronic, Biotronik, Boston scientific and others.

The report titled 'Asia Pacific Cardiac Pacemaker Market Outlook to 2019 - Rise in Cardiac Disorders and Growing Awareness among People to Drive the Demand' provides a comprehensive analysis of cardiac pacemaker market in Asia. The report covers various aspects such as market size of cardiac pacemaker market, segmentation on the basis of therapeutic specification, implantability, number of chambers, and volume of exports and imports for cardiac pacemakers. The report is useful for pharmaceuticals companies, retail chains, consultants, healthcare professionals and new players venturing in the market.

India:

The cardiac pacemaker market in India, which is driven by the development of new and innovative cardiac pacemakers, involving move from pacemakers with VVIR to MRI Pacemakers has registered revenues of INR - million in 2014. With the entry of new cardiac pacemaker manufacturers in the industry, the revenues increased by -% compared to 2013 where the total revenues was INR - million. A major factor that has contributed to such a stupendous growth of this market is advances in technologies. Owing to this advancement in technology, the cardiac health issues are diagnosed much frequently and thus better treatment can be provided to the patients. The cardiac pacemaker market of India has grown at a CAGR of -% from INR - million in 2009 to INR - million in 2014. The main competitors' in India oncology space include Boston scientific, Medtronic and Medived Innovations amongst others. The India Cardiac pacemaker market is expected to grow at a CAGR of 18.5% from 2014-2019 due to greater influx of patients in cardiac care centers which has originated from rising awareness among the people about the right place for best treatment and will continue to escalate the growth of cardiac treatment in India.

China:

China has witnessed continuous and substantial rise in frequency of cardiac cases as well as deaths caused by cardiac disorders. This rapid rise has been attributed to factors such as changing lifestyles and dietary patterns, increasing consumption of tobacco, heavy smoking and several other proximate causes. The revenue of cardiac pacemaker market in China increased by 13.1% compared to 2013 where the total revenues was USD - million. The market has grown at a CAGR of 20.8% from USD -million in 2009 to USD - million in 2014. The China cardiac pacemaker has been anticipated to incline at a CAGR of 20.9% to USD - million in 2019.

Japan:

The cardiac pacemaker market in Japan in the future is envisaged to augment at a CAGR of 13.0% during 2014-2019. The revenues are expected to reach USD - million by 2019. Japan cardiac pacemaker market revenues have inclined at a CAGR of 8.7% from USD - million in 2009 to USD - million in 2014. The cardiac pacemaker market in Japan has been primarily dominated by the internal pacemakers, which has commanded a massive share of -% in the overall revenues of the cardiac pacemaker market during 2014. Japan cardiac pacemaker market in the outlook period, is likely to augment at a positive CAGR of 13.0% during 2014-2019, owing to consistent surging growth of cardiac disorders and innovations by these major players, coupled with enhancement in production capacity as well as extension in the coverage areas, towards newer states and expanding to newer geographies

South Korea:

South Korea's has highly fragmented cardiac pacemaker market, where major proportion of the market being covered by global pharmaceutical companies and very less in hands of local pharmaceutical companies. The sales of pacemaker were registered as USD - million in 2009 which grew at a CAGR of 24.6% to reach USD - million in 2014.

Key Topics Covered:

1. Cardiac Pacemaker Market

2. India Cardiac Hospital Market

3. India Cardiac Pacemaker Market

4. China Cardiac Pacemaker Market

5. Japan Cardiac Pacemaker Market

6. South Korea Cardiac Pacemaker Market Snapshot

7. Asia-Pacific Cardiac Pacemaker Market Future Outlook and Projections, 2015-2019

8. Analyst Recommendations

9. Appendix

Companies Mentioned

- Medtronic

- Sorin Group

- Biotronik

- Boston Scientific Corporation

- St Jude Medical

- Medived Innovations Pvt Ltd

- Qinming Pharmaceuticals Ltd

- Fukuda Denshi

- Japan Lifeline

For more information visit

http://www.researchandmarkets.com/research/lttqph/asia_pacific

Media Contact:

Laura Wood, +353-1-481-1716, press@researchandmarkets.net

Großer Dividenden-Report 2024 von Dr. Dennis Riedl
Der kostenlose Dividenden-Report zeigt ganz genau, wo Sie in diesem Jahr zuschlagen können. Das sind die Favoriten von Börsenprofi Dr. Dennis Riedl
Jetzt hier klicken
© 2015 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.